Free Trial
NASDAQ:ORIC

Oric Pharmaceuticals (ORIC) Stock Price, News & Analysis

Oric Pharmaceuticals logo
$10.78 +0.13 (+1.17%)
As of 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Oric Pharmaceuticals Stock (NASDAQ:ORIC)

Key Stats

Today's Range
$10.60
$10.88
50-Day Range
$4.70
$10.65
52-Week Range
$3.90
$14.67
Volume
232,520 shs
Average Volume
1.13 million shs
Market Capitalization
$918.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.17
Consensus Rating
Buy

Company Overview

Oric Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
83rd Percentile Overall Score

ORIC MarketRank™: 

Oric Pharmaceuticals scored higher than 83% of companies evaluated by MarketBeat, and ranked 171st out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Oric Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Oric Pharmaceuticals has only been the subject of 4 research reports in the past 90 days.

  • Read more about Oric Pharmaceuticals' stock forecast and price target.
  • Earnings Growth

    Earnings for Oric Pharmaceuticals are expected to grow in the coming year, from ($2.17) to ($1.96) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Oric Pharmaceuticals is -5.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Oric Pharmaceuticals is -5.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Oric Pharmaceuticals has a P/B Ratio of 3.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Oric Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    16.01% of the float of Oric Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Oric Pharmaceuticals has a short interest ratio ("days to cover") of 10.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Oric Pharmaceuticals has recently decreased by 4.79%, indicating that investor sentiment is improving.
  • Dividend Yield

    Oric Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Oric Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    16.01% of the float of Oric Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Oric Pharmaceuticals has a short interest ratio ("days to cover") of 10.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Oric Pharmaceuticals has recently decreased by 4.79%, indicating that investor sentiment is improving.
  • News Sentiment

    Oric Pharmaceuticals has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Oric Pharmaceuticals this week, compared to 4 articles on an average week.
  • Search Interest

    5 people have searched for ORIC on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Oric Pharmaceuticals insiders have sold 58.30% more of their company's stock than they have bought. Specifically, they have bought $262,976.00 in company stock and sold $416,289.00 in company stock.

  • Percentage Held by Insiders

    Only 6.82% of the stock of Oric Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    95.05% of the stock of Oric Pharmaceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Oric Pharmaceuticals' insider trading history.
Receive ORIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oric Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ORIC Stock News Headlines

Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…
See More Headlines

ORIC Stock Analysis - Frequently Asked Questions

Oric Pharmaceuticals' stock was trading at $8.07 on January 1st, 2025. Since then, ORIC stock has increased by 32.8% and is now trading at $10.72.
View the best growth stocks for 2025 here
.

Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) released its earnings results on Monday, May, 5th. The company reported ($0.42) earnings per share for the quarter, beating the consensus estimate of ($0.51) by $0.09.

Oric Pharmaceuticals (ORIC) raised $75 million in an IPO on Friday, April 24th 2020. The company issued 5,000,000 shares at $14.00-$16.00 per share. J.P. Morgan, Citigroup, Jefferies and Guggenheim Securities acted as the underwriters for the IPO.

Shares of ORIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oric Pharmaceuticals investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), TotalEnergies (TTE), The RMR Group (RMR) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
5/05/2025
Today
7/03/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ORIC
Fax
N/A
Employees
80
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$19.17
High Stock Price Target
$22.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+78.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$127.85 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$3.45 per share
Price / Book
3.11

Miscellaneous

Free Float
79,412,000
Market Cap
$913.56 million
Optionable
Optionable
Beta
1.54
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:ORIC) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners